Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
9 "Sang Jae Noh"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
Jong Jin Sung, Sang Jae Noh, Jun Sang Bae, Ho Sung Park, Kyu Yun Jang, Myoung Ja Chung, Woo Sung Moon
J Pathol Transl Med. 2016;50(1):52-57.   Published online November 18, 2015
DOI: https://doi.org/10.4132/jptm.2015.10.09
  • 8,521 View
  • 72 Download
  • 18 Web of Science
  • 15 Crossref
AbstractAbstract PDF
Background
Increasing evidence has shown that tumor initiation and growth are nourished by a small subpopulation of cancer stem cells (CSCs) within the tumor mass. CSCs are posited to be responsible for tumor maintenance, growth, distant metastasis, and relapse after curative operation. We examined the expression of CSC markers in paraffin-embedded tissue sections of hepatocellular carcinoma (HCC) and correlated the results with clinicopathologic characteristics. Methods: Immunohistochemical staining for the markers believed to be expressed in the CSCs, including epithelial cell adhesion molecule (EpCAM), keratin 19 (K19), CD133, and CD56, was performed in 82 HCC specimens. Results: EpCAM expression was observed in 56% of the HCCs (46/82) and K19 in 6% (5/82). EpCAM expression in HCC significantly correlated with elevated α-fetoprotein level, microvessel invasion of tumor cells, and high histologic grade. In addition, Ep- CAM expression significantly correlated with K19 expression. The overall survival and relapsefree survival rates in patients with EpCAM-expressing HCC were relatively lower than those in patients with EpCAM-negative HCC. All but two of the 82 HCCs were negative for CD133 and CD56, respectively. Conclusions: Our results suggest that HCCs expressing EpCAM are associated with unfavorable prognostic factors and have a more aggressive clinical course than those not expressing EpCAM. Further, the expression of either CD133 or CD56 in paraffin-embedded HCC tissues appears to be rare.

Citations

Citations to this article as recorded by  
  • Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma
    Narayanan Sadagopan, Aiwu Ruth He
    International Journal of Molecular Sciences.2024; 25(2): 1259.     CrossRef
  • Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis
    Peiwen Ding, Panyu Chen, Jiqi Ouyang, Qiang Li, Shijie Li
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma
    Caecilia Sukowati, Loraine Kay D. Cabral, Beatrice Anfuso, Francesco Dituri, Roberto Negro, Gianluigi Giannelli, Claudio Tiribelli
    International Journal of Molecular Sciences.2023; 24(17): 13357.     CrossRef
  • EpCAM, Ki67, and ESM1 Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Aiat Shaban Hemida, Doha Maher Taie, Moshira Mohamed Abd El-Wahed, Mohammed Ibrahim Shabaan, Mona Saeed Tantawy, Nermine Ahmed Ehsan
    Applied Immunohistochemistry & Molecular Morphology.2023; 31(9): 596.     CrossRef
  • The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers
    Izabela Zarębska, Arkadiusz Gzil, Justyna Durślewicz, Damian Jaworski, Paulina Antosik, Navid Ahmadi, Marta Smolińska-Świtała, Dariusz Grzanka, Łukasz Szylberg
    Clinics and Research in Hepatology and Gastroenterology.2021; 45(3): 101664.     CrossRef
  • Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
    Zhouhong Ge, Jean C.A. Helmijr, Maurice P.H.M. Jansen, Patrick P.C. Boor, Lisanne Noordam, Maikel Peppelenbosch, Jaap Kwekkeboom, Jaco Kraan, Dave Sprengers
    Translational Oncology.2021; 14(7): 101073.     CrossRef
  • Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67
    Asmaa G. Abdou, Nanis S. Holah, Dina S. Elazab, Walaa G. El-Gendy, Mohammed T. Badr, Dalia R. Al-Sharaky
    Applied Immunohistochemistry & Molecular Morphology.2021; 29(1): 20.     CrossRef
  • The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma
    Keigo Murakami, Hiroyuki Kumata, Shigehito Miyagi, Takashi Kamei, Hironobu Sasano
    Pathology International.2021; 71(10): 682.     CrossRef
  • Predictors of recurrence and survival of hepatocellular carcinoma: A prospective study including transient elastography and cancer stem cell markers
    Hend Ibrahim Shousha, Rabab Fouad, Tamer Mahmoud Elbaz, Dina Sabry, Mohamed Mahmoud Nabeel, Ahmed Hosni Abdelmaksoud, Aisha Mahmoud Elsharkawy, Zeinab Abdellatif Soliman, Ghada Habib, Ashraf Omar Abdelaziz
    Arab Journal of Gastroenterology.2020; 21(2): 95.     CrossRef
  • Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
    Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations
    An B. Luong, Huy Q. Do, Paola Tarchi, Deborah Bonazza, Cristina Bottin, Loraine Kay D. Cabral, Long D. C. Tran, Thao P. T. Doan, Lory S. Crocè, Hoa L. T. Pham, Claudio Tiribelli, Caecilia H. C. Sukowati
    Cells.2020; 9(12): 2672.     CrossRef
  • Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
    Hirohisa Okabe, Tomoharu Yoshizumi, Yo-ichi Yamashita, Katsunori Imai, Hiromitsu Hayashi, Shigeki Nakagawa, Shinji Itoh, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Toru Beppu, Shinichi Aishima, Ken Shirabe, Hideo Baba, Yoshihiko Maehara, Motoyuki
    PLOS ONE.2018; 13(9): e0203856.     CrossRef
  • Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma
    Chih‑Jan Ko, Chia‑Jung Li, Meng‑Yu Wu, Pei‑Yi Chu
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
    Wanlu Li, Mi-Ra Lee, EunHee Choi, Mee-Yon Cho
    Journal of Pathology and Translational Medicine.2017; 51(1): 17.     CrossRef
  • PIN1 in hepatocellular carcinoma is associated with TP53 gene status
    Jun Sang Bae, Sang Jae Noh, Kyoung Min Kim, Kyu Yun Jang, Ho Sung Park, Myoung Ja Chung, Byung-Hyun Park, Woo Sung Moon
    Oncology Reports.2016; 36(4): 2405.     CrossRef
Brief Case Reports
Malignant Fat-Forming Solitary Fibrous Tumor of the Thigh
Sang Jae Noh, Kyu Yun Jang
Korean J Pathol. 2014;48(1):69-72.   Published online February 25, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.1.69
  • 5,870 View
  • 46 Download
  • 2 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Fat-forming solitary fibrous tumor of the orbit with typical imaging findings
    Lan Yao, Xinji Yang, Wei Wu
    American Journal of Ophthalmology Case Reports.2024; 33: 101992.     CrossRef
  • Lipomatous hemangiopericytoma of the larynx: An extremely rare tumor at an unusual location
    Kanika Singh, Mukta Pujani, Avani Jain, Aparna Khandelwal
    Saudi Journal for Health Sciences.2021; 10(1): 70.     CrossRef
Nesidioblastosis and Pancreatic Non-functioning Islet Cell Tumor in an Adult with Type 2 Diabetes Mellitus
Ji Eun Choi, Sang Jae Noh, Jong Jin Sung, Woo Sung Moon
Korean J Pathol. 2013;47(5):489-491.   Published online October 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.5.489
  • 7,247 View
  • 64 Download
  • 9 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia
    Martin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, Hendrik Wiethoff, Albrecht Stenzinger, Manuel Röhrich, Uwe Pfeiffer, Wolfgang Rüdiger Kießling, Helena Engel, Harald Sourij, Thorsten Steinberg, Pascal Tomakidi, Stefan Kopf, Julia Szendroedi
    Biomedicines.2023; 11(6): 1732.     CrossRef
  • Postprandial hypoglycemia after upper gastrointestinal tract surgery: prevalence and pathophysiology (part 1)
    M. Yu. Yukina, M. O. Chernova, E. A. Troshina, V. V. Evdoshenko, N. M. Platonova
    Almanac of Clinical Medicine.2021; 49(4): 285.     CrossRef
  • Nésidioblastose traitée par pasiréotide LAR : à propos d’un cas
    Alexia Rouland, Benjamin Bouillet, Pauline Legris, Isabelle Simoneau, Jean-Michel Petit, Bruno Vergès
    Médecine des Maladies Métaboliques.2021; 15(6): 619.     CrossRef
  • Concurrent Adult-Onset Diffuse β-Cell Nesidioblastosis and Pancreatic Neuroendocrine Tumor: A Case Report and Review of the Literature
    Mushfig Orujov, Keith K. Lai, Catherine L. Forse
    International Journal of Surgical Pathology.2019; 27(8): 912.     CrossRef
  • Nesidioblastosis in an Adult with Short Gut Syndrome and Type 2 Diabetes
    Mimi Wong, Luke Conway, Caroline Cooper, Ashim Sinha, Nirjhar Nandi
    AACE Clinical Case Reports.2019; 5(6): e375.     CrossRef
  • Superimposed effect of ovariectomy on type 2 diabetes mellitus in Wistar rats
    Minerva K. Fahmy, Hayam G. Sayyed, Eman A. Abd Elrahim, Rana T.A. Farag
    Alexandria Journal of Medicine.2018; 54(2): 129.     CrossRef
  • Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma
    Keijiro Ueda, Ken Kawabe, Lingaku Lee, Yuichi Tachibana, Nao Fujimori, Hisato Igarashi, Yoshinao Oda, Robert T. Jensen, Ryoichi Takayanagi, Tetsuhide Ito
    Pancreas.2017; 46(4): 476.     CrossRef
  • Nesidioblastosis (diagnosis, surgical treatment)
    A. G. Kriger, A. V. Smirnov, D. V. Kalinin, A. V. Glotov, S. V. Berelavichus, G. I. Konyaeva, A. N. Lebedeva, N. A. Karel’skaya, V. N. Tsygankov
    Khirurgiya. Zhurnal im. N.I. Pirogova.2015; (10): 16.     CrossRef
  • A Rare Complication of Gastric Bypass (Weight Loss) Surgery
    Betül Ünal, Özlem Ceren Uzun, Cumhur İbrahim Başsorgun, Okan Erdoğan, Gülsüm Özlem Elpek
    International Journal of Surgical Pathology.2015; 23(1): 68.     CrossRef
Case Study
Multicystic Biliary Hamartoma of the Liver
Ji Soo Song, Sang Jae Noh, Baik Hwan Cho, Woo Sung Moon
Korean J Pathol. 2013;47(3):275-278.   Published online June 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.3.275
  • 7,231 View
  • 75 Download
  • 15 Crossref
AbstractAbstract PDF

Multicystic biliary hamartoma (MCBH) is a very rare hamartomatous cystic nodule of the liver, which has recently been described as a new entity of a hepatic nodular lesion. We report a unique case of MCBH with a review of the literatures. A hepatic multicystic mass of segment 3 was detected in a 52-year-old male by abdominal computed tomography, and resection of this lesion was performed. Macroscopic examination revealed a 2.7×2.0 cm nodular mass with a multicystic honeycomb cut surface. Histologically, this lesion consisted of multiple dilated cystic ducts lined by biliary type epithelial cells, periductal glands and connective tissue, which included small amounts of hepatic parenchyma and blood vessels. Recognition of this unusual lesion is essential to avoid confusion with other cystic tumors of the liver, and to learn more about its natural history and response to treatment.

Citations

Citations to this article as recorded by  
  • Technical Considerations in EEG Source Imaging
    Benjamin H. Brinkmann
    Journal of Clinical Neurophysiology.2024; 41(1): 2.     CrossRef
  • A Case of Multicystic Biliary Hamartoma with a Marked Peribiliary Gland Component Successfully Treated by Purely Laparoscopic Anatomical Liver Resection
    Keita Kai, Takao Ide, Tomokazu Tanaka, Kumpei Yukimoto, Hiroyuki Irie, Hirokazu Noshiro, Shinichi Aishima
    Journal of Gastrointestinal Cancer.2023; 54(3): 996.     CrossRef
  • Characteristics of multicystic biliary hamartoma: A case report
    Jia Lian, Lixia Sun, Yankai Yang, Jun Li, Ye Zhang, Guiqiu Liu, Weijuan Hu
    Frontiers in Surgery.2023;[Epub]     CrossRef
  • Hamartoma multiquístico de vías biliares
    Victoria Carmona, Iago Justo, Yolanda Rodríguez-Gil, Alberto Marcacuzco, Carmelo Loinaz, Carlos Jiménez
    Cirugía Española.2022; 100(12): 800.     CrossRef
  • Multicystic Biliary Hamartoma With Xanthogranulomatous Inflammation on 18F-FDG PET/CT
    Nahomi Shono, Yoichi Otomi, Hideki Otsuka, Takayoshi Shinya, Masafumi Harada
    Clinical Nuclear Medicine.2022; 47(10): 882.     CrossRef
  • Intrahepatic multicystic biliary hamartoma: A case report
    Chen-Yu Wang, Fu-Yang Shi, Wei-Feng Huang, Yan Tang, Ting Li, Guo-Lin He
    World Journal of Clinical Cases.2022; 10(26): 9361.     CrossRef
  • A Case of Multicystic Biliary Hamartoma Treated with Left Medial Sectionectomy
    Naomi KUROKI, Tomoaki TANAKA, Takanobu SUGASE, Syoji TANIGUCHI, Takashi GOTO, Rintaro KOGA, Takumi KIWAKI, Hiroyuki TANAKA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2022; 83(2): 395.     CrossRef
  • Multicystic biliary hamartoma
    Victoria Carmona, Iago Justo, Yolanda Rodríguez-Gil, Alberto Marcacuzco, Carmelo Loinaz, Carlos Jiménez
    Cirugía Española (English Edition).2022; 100(12): 800.     CrossRef
  • Case Report: Incidentally Discovered a Rare Cystic Lesion of Liver: Multicystic Biliary Hamartoma
    Wentao Mu, Peng Su, Shanglei Ning
    Pathology and Oncology Research.2021;[Epub]     CrossRef
  • Bile Duct Hamartoma Mimicking Liver Metastasis in Suspected Porcelain Gallbladder: a Case Report
    Gautham Krishnamurthy, Harjeet Singh, Sravya Deepika Ganti, Ganga Ram Verma
    Journal of Gastrointestinal Cancer.2019; 50(4): 1022.     CrossRef
  • A variant of multicystic biliary hamartoma presenting as an intrahepatic cystic neoplasm
    Tetsuro Tominaga, Takafumi Abo, Naoe Kinoshita, Tomonori Murakami, Yasunori Sato, Yasuni Nakanuma, Kenich Harada, Junichi Masuda, Takeshi Nagayasu, Atsushi Nanashima
    Clinical Journal of Gastroenterology.2015; 8(3): 162.     CrossRef
  • Hamartoma biliar multiquístico intrahepático: presentación de un caso clínico
    María Jezabel Fernández-Carrión, Ricardo Robles Campos, Asunción López Conesa, Roberto Brusadín, Pascual Parrilla Paricio
    Cirugía Española.2015; 93(9): e103.     CrossRef
  • Intrahepatic Multicystic Biliary Hamartoma: Presentation of a Case Report
    María Jezabel Fernández-Carrión, Ricardo Robles Campos, Asunción López Conesa, Roberto Brusadín, Pascual Parrilla Paricio
    Cirugía Española (English Edition).2015; 93(9): e103.     CrossRef
  • Multicystic biliary hamartoma: A report of a rare entity and a review of the literature
    Rachel E. Beard, Eric U. Yee, Koenraad J. Mortele, Khalid Khwaja
    International Journal of Surgery Case Reports.2014; 5(12): 919.     CrossRef
  • Multicystic biliary hamartoma mimicking intrahepatic cholangiocarcinoma: report of a case
    Tomoaki Yoh, Ryuji Okamura, Hiroyuki Nakayama, Xue Lin, Yuya Nakamura, Tatsushi Kato
    Clinical Journal of Gastroenterology.2014; 7(5): 418.     CrossRef
Brief Case Report
Mucinous Non-neoplastic Cyst of the Pancreas
Jae Do Yang, Ji Soo Song, Sang Jae Noh, Woo Sung Moon
Korean J Pathol. 2013;47(2):188-190.   Published online April 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.2.188
  • 6,434 View
  • 41 Download
  • 5 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Simple mucinous cyst: another potential cancer precursor in the pancreas? Case report with molecular characterization and systematic review of the literature
    Anna Caterina Milanetto, Alice Sabrina Tonello, Giovanni Valotto, Giada Munari, Claudio Luchini, Matteo Fassan, Claudio Pasquali
    Virchows Archiv.2021; 479(1): 179.     CrossRef
  • Mucinous Non-neoplastic Cyst of the Pancreas
    Jun Hyung Kim, Dong Eun Park, Keum Ha Choi
    The Korean Journal of Gastroenterology.2019; 73(4): 235.     CrossRef
  • Mucinous nonneoplastic cyst of the pancreas: CT and MRI appearances
    Kousei Ishigami, Akihiro Nishie, Naoki Mochidome, Yoshiki Asayama, Yasuhiro Ushijima, Daisuke Kakihara, Daisuke Okamoto, Nobuhiro Fujita, Takao Ohtsuka, Yoshihiro Miyasaka, Tomoyuki Hida, Tomoharu Yoshizumi, Hiroshi Honda
    Abdominal Radiology.2017; 42(12): 2827.     CrossRef
  • Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract
    Volkan Adsay, Mari Mino-Kenudson, Toru Furukawa, Olca Basturk, Giuseppe Zamboni, Giovanni Marchegiani, Claudio Bassi, Roberto Salvia, Giuseppe Malleo, Salvatore Paiella, Christopher L. Wolfgang, Hanno Matthaei, G. Johan Offerhaus, Mustapha Adham, Marco J.
    Annals of Surgery.2016; 263(1): 162.     CrossRef
  • Rare Nonneoplastic Cysts of Pancreas
    Yeon Suk Kim, Jae Hee Cho
    Clinical Endoscopy.2015; 48(1): 31.     CrossRef
Original Article
Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication
Tack Kune You, Kyoung Min Kim, Sang Jae Noh, Jun Sang Bae, Kyu Yun Jang, Myoung Ja Chung, Woo Sung Moon, Myoung Jae Kang, Dong Geun Lee, Ho Sung Park
Korean J Pathol. 2012;46(4):331-340.   Published online August 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.4.331
  • 7,472 View
  • 56 Download
  • 13 Crossref
AbstractAbstract PDF
Background

E-cadherin, cortactin, and matrix metalloproteinase (MMP)-9 have roles in tumor development or progression, but their expression has not been fully investigated in pseudoepitheliomatous hyperplasia (PEH) and squamous cell carcinoma (SCC) of the head and neck.

Methods

We evaluated the immunohistochemical expression of E-cadherin, cortactin, and MMP-9 in 29 cases of PEH and 97 cases of SCC. Additionally, we evaluated their relationship with clinicopathologic factors and prognostic implications in SCC.

Results

Thirty-five cases of SCC showed reduced expression of E-cadherin, whereas none of the PEH did. A total of 20 cases and 11 cases of SCC were immunoreactive for cortactin and MMP-9, respectively, whereas none of the PEH did. In SCC, reduced expression of E-cadherin was correlated with cortactin expression and invasion depth. Cortactin expression was correlated with differentiation, T classification, and recurrence and/or metastasis. MMP-9 expression was correlated with invasion depth. Cortactin expression was correlated with poor overall survival and relapse-free survival and it was an independent prognostic factor.

Conclusions

The reduced expression of E-cadherin and the expression of cortactin may be helpful for the differential diagnosis of PEH and SCC. Furthermore, cortactin expression in association with reduced E-cadherin expression is correlated with poor prognosis in SCC.

Citations

Citations to this article as recorded by  
  • Virus-associated disruption of mucosal epithelial tight junctions and its role in viral transmission and spread
    Sharof Tugizov
    Tissue Barriers.2021;[Epub]     CrossRef
  • Leishmaniasis: still a diagnostic challenge?
    Ricardo Tadeu Villa
    Journal of Dermatology & Cosmetology.2021; 5(2): 23.     CrossRef
  • COMPARISON OF EXPRESSION OF E-CADHERIN IN ORAL PSEUDOEPITHELIOMATOUS HYPERPLASIA AND ORAL SQUAMOUS CELL CARCINOMA
    Ayesha Mukhtar Awan, Iram Naz, Muhammad Khurram Mahmood, Hafeez Uddin
    Gomal Journal of Medical Sciences.2020; 17(3): 70.     CrossRef
  • EXPRESSION OF MATRIX METALLOPROTEINASE-9 IN ORAL SQUAMOUS CELL CARCINOMA AND ORAL PSEUDOEPITHELIOMATOUS HYPERPLASIA
    Ayesha Mukhtar Awan, Iram Naz, Muhammad Khurram Mahmood, Hafeez Uddin
    Gomal Journal of Medical Sciences.2020; 18(01): 24.     CrossRef
  • An update of knowledge on cortactin as a metastatic driver and potential therapeutic target in oral squamous cell carcinoma
    Pablo Ramos‐García, Miguel Ángel González‐Moles, Lucía González‐Ruiz, Ángela Ayén, Isabel Ruiz‐Ávila, Francisco José Navarro‐Triviño, José Antonio Gil‐Montoya
    Oral Diseases.2019; 25(4): 949.     CrossRef
  • Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta‐analysis
    Pablo Ramos‐García, Miguel Ángel González‐Moles, Ángela Ayén, Lucía González‐Ruiz, Isabel Ruiz‐Ávila, José Antonio Gil‐Montoya
    Head & Neck.2019; 41(6): 1963.     CrossRef
  • The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer
    Shuang‑Yan Lin, Yan‑Bo Lv, Gen‑Xiang Mao, Xu‑Jiao Chen, Fang Peng
    Oncology Letters.2018;[Epub]     CrossRef
  • Glycosylation: a hallmark of cancer?
    Bhairavi N. Vajaria, Prabhudas S. Patel
    Glycoconjugate Journal.2017; 34(2): 147.     CrossRef
  • Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance
    Seong Uk Jeh, Jung Je Park, Jong Sil Lee, Dong Chul Kim, Jungmo Do, Sin Woo Lee, See Min Choi, Jae Seog Hyun, Deok Ha Seo, Chunwoo Lee, Sung Chul Kam, Ky Hyun Chung, Jeong Seok Hwa
    Urologic Oncology: Seminars and Original Investigations.2017; 35(12): 675.e9.     CrossRef
  • Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway
    Xiaojian Zhang, Kun Liu, Tao Zhang, Zhenlei Wang, Xuan Qin, Xiaoqian Jing, Haoxuan Wu, Xiaopin Ji, Yonggang He, Ren Zhao
    Oncotarget.2017; 8(1): 1541.     CrossRef
  • Cortactin in cancer cell migration and invasion
    Miao Yin, Wenqing Ma, Liguo An
    Oncotarget.2017; 8(50): 88232.     CrossRef
  • Association of SIRT1 and HMGA1 expression in non-small cell lung cancer
    SHUANG-YAN LIN, FANG PENG
    Oncology Letters.2016; 11(1): 782.     CrossRef
  • Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer
    Sang Jae Noh, Hyun Ah Baek, Ho Sung Park, Kyu Yun Jang, Woo Sung Moon, Myoung Jae Kang, Dong Geun Lee, Min Ho Kim, Ju Hyung Lee, Myoung Ja Chung
    Pathology - Research and Practice.2013; 209(6): 365.     CrossRef
Case Reports
In Situ Follicular Lymphoma Developed after Hodgkin Lymphoma.
Ho Sung Park, Sang Jae Noh, Jae Yong Kwak, Eun Kee Song, Myung Hee Sohn, Ho Lee, Woo Sung Moon, Kyu Yun Jang
Korean J Pathol. 2011;45:S53-S57.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.S1.S53
  • 2,840 View
  • 20 Download
AbstractAbstract PDF
In situ follicular lymphoma is a newly defined entity among the lymphoid neoplasms and is defined as architecturally normal-appearing lymph nodes and other lymphoid tissues that have one or more follicles that demonstrate bcl-2 overexpressing centrocytes and centroblasts, with or without a monomorphic cytologic appearance suggestive of follicular lymphoma. Here we present a case of in situ follicular lymphoma diagnosed during the follow-up after a complete response to the treatment of lymphocyte-rich classical Hodgkin's lymphoma. In our case, because only a few germinal centers contained bcl-2 overexpressing cells, we missed the diagnosis of in situ follicular lymphoma in the initial histological examination. We could establish the diagnosis only after performing bcl-2 immunostaining in the sequential biopsy. Therefore, we recommend that careful histological examination along with bcl-2 immunostaining is needed in patients with suspicious clinical findings.
Solitary Fibrous Tumor of the Liver: A Case Report.
Hee Chul Yu, Baik Hwan Cho, Young Kon Kim, Sang Jae Noh, Woo Sung Moon
Korean J Pathol. 2010;44(5):536-539.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.5.536
  • 3,156 View
  • 21 Download
  • 1 Crossref
AbstractAbstract PDF
Solitary fibrous tumor is an uncommon neoplasm of mesenchymal origin that primarily affects the pleura. This tumor has been rarely found in liver parenchyma. We present an additional case of a solitary fibrous tumor in the liver of a 46-year-old woman. A contrast-enhanced magnetic resonance image revealed a well-defined round hepatic mass with strong homogeneous enhancement on arterial phase imaging. The tumor was composed of cytologically bland spindle cells with alternating hypercellular and hypocellular sclerotic areas. Immunohistochemistry indicated that the tumor cells were positive for vimentin, CD34, CD99 and smooth muscle actin, but negative for cytokeratin, human melanoma black 45, CD117, bcl-2, and S-100 protein.

Citations

Citations to this article as recorded by  
  • Meningeal Solitary Fibrous Tumors with Delayed Extracranial Metastasis
    Nayoung Han, Hannah Kim, Soo Kee Min, Sun-Ha Paek, Chul-Kee Park, Seung-Hong Choi, U-Ri Chae, Sung-Hye Park
    Journal of Pathology and Translational Medicine.2016; 50(2): 113.     CrossRef
Original Article
The Prognostic Significance of the Tumor-Infiltrating FoxP3-Positive Regulatory T Cells in Gastric Carcinoma.
Sang Jae Noh, Shin Young Park, Kyung Ryoul Kim, Chan Young Kim, Keun Sang Kwon, Ho Sung Park, Ho Lee, Myoung Ja Chung, Woo Sung Moon, Kyu Yun Jang
Korean J Pathol. 2010;44(1):9-15.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.1.9
  • 3,362 View
  • 31 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Regulatory T cells (Tregs) are known to be key regulators of immune responses in patients with autoimmune disease and infection and also for attenuating antitumor immunity by the host. It has been reported that high numbers of tumor-infiltrating Tregs might be associated with poor clinical outcomes for several malignant tumors. Therefore, this study aimed to examine the impact of tumor-infiltrating Tregs on the prognosis of gastric carcinoma patients.
METHODS
The immunohistochemical staining for anti-fork head Box P3 (FoxP3) antibody was performed by using a 3 mm core from the tumor specimens of each of the 173 gastric cancer patients for constructing a tissue microarray. FoxP3-positive Tregs were quantified by calculating the numbers of positive cells per 5 high-power fields on light microscopy. Thereafter, the 173 patients were subdivided into the low Tregs group (< or = 3/5 high power fields [HPF], n = 41) and the high Tregs group (> 3/5 HPF, n = 132).
RESULTS
The high Tregs group was significantly associated with a higher stage, more invasion depth and lymph node metastasis (p = 0.009, p = 0.036, p = 0.006, respectively). The high Tregs group showed significantly poorer overall survival and event-free survival (p = 0.004, p = 0.017, respectively) on the univariate analysis. The Tregs group and the tumor, node and metastasis stage were also independent prognostic factors that were significantly associated with overall survival (p = 0.025, p < 0.001, respectively) by multivariate analysis.
CONCLUSIONS
Our results indicated that a high number of tumor-infiltrating FoxP3-positive Tregs could be an indicator of poor long term survival for gastric carcinoma patients.

Citations

Citations to this article as recorded by  
  • Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma
    Myoung Jae Kang, Kyoung Min Kim, Jun Sang Bae, Ho Sung Park, Ho Lee, Myoung Ja Chung, Woo Sung Moon, Dong Geun Lee, Kyu Yun Jang
    Translational Oncology.2013; 6(3): 282.     CrossRef
  • Significance of Foxp3 Positive Regulatory T Cell and Tumor Infiltrating T Lymphocyte in Triple Negative Breast Cancer
    Hanna Kang, Harin Cheong, Min Sun Cho, Heasoo Koo, Woon Sup Han, Kyung Eun Lee, Byung In Moon, Sun Hee Sung
    The Korean Journal of Pathology.2011; 45(1): 53.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine